What's breaking now, across thousands of outlets.
Eli Lilly plans to seek approval of its obesity med in obstructive sleep apnea after a positive Phase 3 trial, potentially giving it a new way to compete with Novo's far-better-selling Wegovy ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
Novartis is largely abandoning a drug once considered a potential blockbuster after a study found it had little promise for preventing heart attacks and deaths
Former president’s new book Promise Me America provides an inside look at January 6, Covid-19 response and more Joe Biden will undertake only limited promotion of his upcoming White House memoir…
The disgraced comedian was convicted on Thursday of raping one woman and sexually assaulting three more between 2004 and 2009.
University of California, Riverside, scientists have an explanation for why males and females respond differently to obesity.
Swapping refined grains and butter for oats, rye, rapeseed oil, legumes and fatty fish could improve cholesterol, blood sugar and inflammation.
